{"id":"https://openalex.org/W2168189794","doi":"https://doi.org/10.2337/diabetes.51.5.1453","title":"A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal","display_name":"A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal","alternate_titles":[],"publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2168189794","doi":"https://doi.org/10.2337/diabetes.51.5.1453","mag":"2168189794","pmid":"https://pubmed.ncbi.nlm.nih.gov/11978642"},"language":"en","primary_location":{"id":"doi:10.2337/diabetes.51.5.1453","doi":"https://doi.org/10.2337/diabetes.51.5.1453","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diabetes.51.5.1453","pdf_url":"https://diabetesjournals.org/diabetes/article-pdf/51/5/1453/658739/db0502001453.pdf","source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2168189794"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://diabetesjournals.org/diabetes/article-pdf/51/5/1453/658739/db0502001453.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062858105","display_name":"Manami Tsutsumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Manami Tsutsumi","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110358113","display_name":"Thomas H. Claus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas H. Claus","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100601141","display_name":"Yin Tong Liang","orcid":"https://orcid.org/0000-0003-3192-1948","observed_orcids":["https://orcid.org/0000-0003-3192-1948"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yin Liang","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378846","display_name":"Yaxin Li","orcid":"https://orcid.org/0000-0002-5871-9806","observed_orcids":["https://orcid.org/0000-0002-5871-9806"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yaxin Li","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023793674","display_name":"Ling Yang","orcid":"https://orcid.org/0000-0002-4045-7457","observed_orcids":["https://orcid.org/0000-0002-4045-7457"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ling Yang","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071972493","display_name":"Jian Zhu","orcid":"https://orcid.org/0000-0003-0171-4251","observed_orcids":["https://orcid.org/0000-0003-0171-4251","https://orcid.org/0000-0001-9614-257X"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jian Zhu","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109195026","display_name":"Fernando Dela Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fernando Dela Cruz","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027720577","display_name":"Xianbu Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xianbu Peng","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064429875","display_name":"Hongxing Chen","orcid":"https://orcid.org/0000-0002-1413-6051","observed_orcids":["https://orcid.org/0000-0002-1413-6051"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hongxing Chen","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086614042","display_name":"Stephanie L. Yung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephanie L. Yung","raw_affiliation_strings":["Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052691662","display_name":"Sarah Hamren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Hamren","raw_affiliation_strings":["Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114009400","display_name":"James N. Livingston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James N. Livingston","raw_affiliation_strings":["Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Metabolic Disorders Research, Pharmaceutical Division, Bayer Corporation, West Haven, Connecticut","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076375328","display_name":"Clark Q. Pan","orcid":"https://orcid.org/0000-0001-5110-1803","observed_orcids":["https://orcid.org/0000-0001-5110-1803"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Clark Q. Pan","raw_affiliation_strings":["Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Technologies, Biotechnology, Bayer Corporation, Berkeley, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076375328"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0916,"has_fulltext":true,"cited_by_count":138,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92567725,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"51","issue":"5","first_page":"1453","last_page":"1460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.10239999741315842,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vpac2","display_name":"VPAC2","score":0.7919999957084656},{"id":"https://openalex.org/keywords/pituitary-adenylate-cyclase-activating-peptide","display_name":"pituitary adenylate cyclase-activating peptide","score":0.9039999842643738},{"id":"https://openalex.org/keywords/vasoactive-intestinal-peptide","display_name":"vasoactive intestinal peptide","score":0.9800000190734863},{"id":"https://openalex.org/keywords/selective-agonists","display_name":"selective agonists","score":0.7519999742507935},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.875},{"id":"https://openalex.org/keywords/glucose-disposal","display_name":"glucose disposal","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pancreatic-islets","display_name":"pancreatic islets","score":0.843999981880188},{"id":"https://openalex.org/keywords/type-2-diabetes-treatment","display_name":"type 2 diabetes treatment","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hepatic-glucose-production","display_name":"hepatic glucose production","score":0.796999990940094},{"id":"https://openalex.org/keywords/peptide-analog-design","display_name":"peptide analog design","score":0.3529999852180481},{"id":"https://openalex.org/keywords/site-directed-mutagenesis","display_name":"site-directed mutagenesis","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7956038117408752},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7888934016227722},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.741811215877533},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6792547702789307},{"id":"https://openalex.org/C8330315","wikidata":"https://www.wikidata.org/wiki/Q414964","display_name":"Vasoactive intestinal peptide","level":4,"score":0.5652019381523132},{"id":"https://openalex.org/C2779855799","wikidata":"https://www.wikidata.org/wiki/Q728309","display_name":"Pancreatic islets","level":4,"score":0.5318873524665833},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49298974871635437},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4645635187625885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.370685338973999},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.285164475440979},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.20031270384788513},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16824883222579956}],"mesh":[{"descriptor_ui":"D000078790","descriptor_name":"Insulin Secretion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006728","descriptor_name":"Hormones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011979","descriptor_name":"Receptors, Pituitary Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014660","descriptor_name":"Vasoactive Intestinal Peptide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014660","descriptor_name":"Vasoactive Intestinal Peptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014660","descriptor_name":"Vasoactive Intestinal Peptide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014660","descriptor_name":"Vasoactive Intestinal Peptide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018005","descriptor_name":"Receptors, Vasoactive Intestinal Peptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018005","descriptor_name":"Receptors, Vasoactive Intestinal Peptide","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D051236","descriptor_name":"Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051238","descriptor_name":"Receptors, Vasoactive Intestinal Polypeptide, Type I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051239","descriptor_name":"Receptors, Vasoactive Intestinal Peptide, Type II","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2337/diabetes.51.5.1453","doi":"https://doi.org/10.2337/diabetes.51.5.1453","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diabetes.51.5.1453","pdf_url":"https://diabetesjournals.org/diabetes/article-pdf/51/5/1453/658739/db0502001453.pdf","source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},{"id":"pmid:11978642","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11978642","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.923.242","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.923.242","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://diabetes.diabetesjournals.org/content/51/5/1453.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/diabetes.51.5.1453","doi":"https://doi.org/10.2337/diabetes.51.5.1453","is_oa":true,"landing_page_url":"https://doi.org/10.2337/diabetes.51.5.1453","pdf_url":"https://diabetesjournals.org/diabetes/article-pdf/51/5/1453/658739/db0502001453.pdf","source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2168189794.pdf","grobid_xml":"https://content.openalex.org/works/W2168189794.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1513662526","https://openalex.org/W1547329911","https://openalex.org/W1655779417","https://openalex.org/W1674418446","https://openalex.org/W1969209468","https://openalex.org/W1971371480","https://openalex.org/W1971847412","https://openalex.org/W1973351394","https://openalex.org/W1975236725","https://openalex.org/W1981423842","https://openalex.org/W2000465889","https://openalex.org/W2007276031","https://openalex.org/W2012455087","https://openalex.org/W2013842626","https://openalex.org/W2016193410","https://openalex.org/W2017518223","https://openalex.org/W2021613066","https://openalex.org/W2022101780","https://openalex.org/W2029521461","https://openalex.org/W2032350393","https://openalex.org/W2033650768","https://openalex.org/W2034020880","https://openalex.org/W2036471756","https://openalex.org/W2038671755","https://openalex.org/W2040058024","https://openalex.org/W2047601887","https://openalex.org/W2059835695","https://openalex.org/W2063606998","https://openalex.org/W2077478791","https://openalex.org/W2084534846","https://openalex.org/W2087104875","https://openalex.org/W2092510134","https://openalex.org/W2099468352","https://openalex.org/W2101248375","https://openalex.org/W2107729314","https://openalex.org/W2130207292","https://openalex.org/W2130922427","https://openalex.org/W2137473529","https://openalex.org/W2139880338","https://openalex.org/W2140137473","https://openalex.org/W2143742033","https://openalex.org/W2151875422","https://openalex.org/W2155633307","https://openalex.org/W2159128174","https://openalex.org/W2171404549","https://openalex.org/W2171988137","https://openalex.org/W2304992373","https://openalex.org/W2323160699","https://openalex.org/W2743393802","https://openalex.org/W4211118882","https://openalex.org/W4406065649"],"related_works":["https://openalex.org/W2152866561","https://openalex.org/W4297907343","https://openalex.org/W7100144846","https://openalex.org/W2038039362","https://openalex.org/W2153342360","https://openalex.org/W2067448331","https://openalex.org/W2104976814","https://openalex.org/W2105007632","https://openalex.org/W1978674672","https://openalex.org/W1547329911"],"abstract_inverted_index":{"Pituitary":[0],"adenylate":[1],"cyclase-activating":[2],"peptide":[3,8,86,151,166],"(PACAP)":[4],"and":[5,15,82,98,113,124,173],"vasoactive":[6],"intestinal":[7,170],"(VIP)":[9],"activate":[10],"two":[11],"shared":[12],"receptors,":[13],"VPAC1":[14,19],"VPAC2.":[16,65],"Activation":[17],"of":[18,29,64,79,95,141,149,196],"has":[20],"been":[21],"implicated":[22],"in":[23,34,110,120,129,133,178],"elevating":[24],"glucose":[25,45,55,154,162],"output,":[26],"whereas":[27],"activation":[28],"VPAC2":[30,89],"may":[31,188],"be":[32,189],"involved":[33],"insulin":[35,49,108,118,131],"secretion.":[36],"A":[37],"hypothesis":[38],"that":[39],"a":[40,60,91,126,137,190],"VPAC2-selective":[41],"agonist":[42,63],"would":[43],"enhance":[44],"disposal":[46],"by":[47],"stimulating":[48],"secretion":[50,109],"without":[51],"causing":[52],"increased":[53,117],"hepatic":[54],"production":[56],"was":[57,70],"tested":[58],"using":[59],"novel":[61],"selective":[62],"This":[66],"agonist,":[67],"BAY":[68,104,186],"55-9837,":[69],"generated":[71],"through":[72],"site-directed":[73],"mutagenesis":[74],"based":[75],"on":[76,169],"sequence":[77],"alignments":[78],"PACAP,":[80],"VIP,":[81],"related":[83],"analogs.":[84],"The":[85,165],"bound":[87],"to":[88],"with":[90,136],"dissociation":[92],"constant":[93],"(K(d))":[94],"0.65":[96],"nmol/l":[97],"displayed":[99],">100-fold":[100],"selectivity":[101],"over":[102],"VPAC1.":[103],"55-9837":[105,187],"stimulated":[106],"glucose-dependent":[107],"isolated":[111],"rat":[112,122],"human":[114],"pancreatic":[115],"islets,":[116,123],"synthesis":[119],"purified":[121],"caused":[125],"dose-dependent":[127],"increase":[128],"plasma":[130],"levels":[132],"fasted":[134],"rats,":[135,179],"half-maximal":[138],"stimulatory":[139],"concentration":[140],"3":[142],"pmol/kg.":[143],"Continuous":[144],"intravenous":[145],"or":[146],"subcutaneous":[147],"infusion":[148],"the":[150,153,157,194],"reduced":[152],"area":[155],"under":[156],"curve":[158],"following":[159],"an":[160],"intraperitoneal":[161],"tolerance":[163],"test.":[164],"had":[167],"effects":[168],"water":[171],"retention":[172],"mean":[174],"arterial":[175],"blood":[176],"pressure":[177],"but":[180],"only":[181],"at":[182],"much":[183],"higher":[184],"doses.":[185],"useful":[191],"therapy":[192],"for":[193],"treatment":[195],"type":[197],"2":[198],"diabetes.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2168189794","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
